Home › NDC Lookup › RxCUI directory › RxCUI 198175

Propylthiouracil 50 MG Oral Tablet — RxCUI 198175

Name: Propylthiouracil 50 MG Oral Tablet (RxCUI 198175)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 198175 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198175

Official namePropylthiouracil 50 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asPTU 50 MG Oral Tablet

FDA products mapped8

Package NDCs mapped13

Reported Medicaid activity (SDUD)15,946 prescriptions · 39 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Propylthiouracil: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It treats an overactive thyroid, specifically Graves’ disease with hyperthyroidism or toxic multinodular goiter. It is for people who cannot tolerate methimazole. It is also used t...
You take the tablets by mouth, usually split into 3 equal doses about 8 hours apart. Your doctor will adjust your dose based on thyroid blood tests. Follow your pharmacy label and...
Severe liver injury, which can be life-threatening. Call your doctor right away if you lose your appetite, have itching, pain in the upper right belly, or yellowing of your skin or...
Call your doctor immediately. These can be signs of agranulocytosis, a serious drop in infection-fighting white blood cells. It most often happens in the first 3 months.

📖 Read our full Propylthiouracil guide →

🕸️ Concept Web — How Propylthiouracil 50 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Propylthiouracil 50 MG Oral Tablet RxCUI 198175 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Propylthiouracil 8794 IN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Propylthiouracil Oral Tablet 373658 SCDF
- Propylthiouracil Oral Product 1162944 SCDG
- Propylthiouracil Pill 1162945 SCDG
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- Pill 1151133 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Propylthiouracil 50 MG 316601 SCDC

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Propylthiouracil 50 MG SCDC · 316601
Propylthiouracil Oral Tablet SCDF · 373658
Propylthiouracil Oral Product SCDG · 1162944
Propylthiouracil Pill SCDG · 1162945

📦 FDA Products & Package NDCs

8 products · 13 package NDCs

13 package NDCs map to RxCUI 198175 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00480-9242-01	100 TABLET in 1 BOTTLE (0480-9242-01)	Propylthiouracil	Teva Pharmaceuticals, Inc.	2024-07-10
33342-0314-11	100 TABLET in 1 BOTTLE (33342-314-11)	Propylthiouracil	Macleods Pharmaceuticals Limited	2023-05-10
33342-0314-12	10 BLISTER PACK in 1 CARTON (33342-314-12) / 10 TABLET in 1...	Propylthiouracil	Macleods Pharmaceuticals Limited	2023-05-10
33342-0314-44	1000 TABLET in 1 BOTTLE (33342-314-44)	Propylthiouracil	Macleods Pharmaceuticals Limited	2023-05-10
62135-0606-90	90 TABLET in 1 BOTTLE (62135-606-90)	Propylthiouracil	Chartwell RX, LLC	2023-12-19
67253-0651-10	100 TABLET in 1 BOTTLE (67253-651-10)	Propylthiouracil	Endo USA, Inc.	1947-07-28
67253-0651-11	1000 TABLET in 1 BOTTLE (67253-651-11)	Propylthiouracil	Endo USA, Inc.	1947-07-28
68084-0964-25	30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-964-25) / 1 TABL...	Propylthiouracil	American Health Packaging	2015-10-08
70752-0171-10	100 TABLET in 1 BOTTLE (70752-171-10)	PROPYLTHIOURACIL	QUAGEN PHARMACEUTICALS LLC	2021-03-18
70752-0171-11	1000 TABLET in 1 BOTTLE (70752-171-11)	PROPYLTHIOURACIL	QUAGEN PHARMACEUTICALS LLC	2021-03-18
71335-2901-01	100 TABLET in 1 BOTTLE (71335-2901-1)	PROPYLTHIOURACIL	Bryant Ranch Prepack	2025-11-11
72162-2072-01	100 TABLET in 1 BOTTLE (72162-2072-1)	PROPYLTHIOURACIL	Bryant Ranch Prepack	2023-08-15
72162-2072-02	180 TABLET in 1 BOTTLE (72162-2072-2)	PROPYLTHIOURACIL	Bryant Ranch Prepack	2023-08-15

Observed labelers: Bryant Ranch Prepack (3) · Macleods Pharmaceuticals Limited (3) · Endo USA, Inc. (2) · QUAGEN PHARMACEUTICALS LLC (2) · American Health Packaging (1) · Chartwell RX, LLC (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ea · median

$0.2814

Range $0.2814–$0.2814 · middle 50% $0.2814–$0.2814 · 7 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.